Abstract 13232: Prokineticin as a Biomarker of Cardiotoxicity in Cancer Patients

Canan G Nebigil, Anaïs AUDEBRAND, Daniela Cardinale

Open source

DOI: 10.1161/circ.144.suppl_1.13232
Published: 2021-11-16
Container: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/circ.144.suppl_1.13232,
  title = {Abstract 13232: Prokineticin as a Biomarker of Cardiotoxicity in Cancer Patients},
  author = {Canan G Nebigil and Anaïs AUDEBRAND and Daniela Cardinale},
  year = {2021},
  journal = {Circulation},
  doi = {10.1161/circ.144.suppl_1.13232},
  url = {https://doi.org/10.1161/circ.144.suppl_1.13232}
}

RIS

TY  - JOUR
TI  - Abstract 13232: Prokineticin as a Biomarker of Cardiotoxicity in Cancer Patients
AU  - Canan G Nebigil
AU  - Anaïs AUDEBRAND
AU  - Daniela Cardinale
PY  - 2021
JO  - Circulation
DO  - 10.1161/circ.144.suppl_1.13232
UR  - https://doi.org/10.1161/circ.144.suppl_1.13232
ER  -

APA

Nebigil, C. G., AUDEBRAND, A., & Cardinale, D. (2021). Abstract 13232: Prokineticin as a Biomarker of Cardiotoxicity in Cancer Patients. Circulation. https://doi.org/10.1161/circ.144.suppl_1.13232

Source records

crossref · retrieved 2026-11-04T19:43:51.808Z